Overview
Semaglutide is a potent GLP-1 (Glucagon-Like Peptide-1) receptor agonist originally developed to manage Type 2 diabetes but widely recognized for its profound effects on weight loss. It functions by mimicking a natural hormone that targets areas of the brain involved in appetite regulation. By slowing down the digestive process and signaling the brain that the body is satisfied, it helps users maintain a significant caloric deficit with less effort.
Beyond its role in fat loss, Semaglutide provides cardiovascular benefits and helps stabilize blood sugar levels, reducing the long-term risks of heart attack and stroke. While it is highly effective at managing insulin resistance, it is not a treatment for Type 1 diabetes. For optimal results in body composition, it is typically used in conjunction with a high-protein diet and consistent resistance training to preserve lean muscle mass while adipose tissue is reduced.
Mechanism of action
Acts as a GLP-1 receptor agonist that enhances glucose-dependent insulin secretion, suppresses glucagon, and delays gastric emptying to regulate energy intake.
Reported benefits
- ▸Significant appetite suppression for chronic weight management
- ▸Improved glycemic control by stimulating insulin secretion
- ▸Reduces risk of major adverse cardiovascular events (MACE)
- ▸Slows gastric emptying to increase feelings of satiety
- ▸Lowers systemic inflammation associated with high blood sugar
- ▸Effective for rapid weight loss when combined with lifestyle changes
Reported side effects
- ·Nausea
- ·Vomiting
- ·Diarrhea or constipation
- ·Hypoglycemia (low blood sugar)
- ·Injection site pain
- ·Fatigue
Often stacked with
B-12ElectrolytesMetforminGlutathione